Back to the program

Community-Acquired Pneumonia in departement of ibn jazzar kairouin

Mabrouk IMEN, Imen KandATA, Raja GALAI and Ines DALI

Community-acquired pneumonia (CAP) is a major public health problem and remains one of the leading causes of morbidity and mortality related to infectious diseases. It is also among the most common reasons for consultation in emergency departments.This study aims to describe the epidemiological, clinical, paraclinical, therapeutic, and evolutionary characteristics of patients managed for CAP in the emergency department of Ibn Jazzar Hospital in Kairouan, and to evaluate hospitalization and orientation strategies.This was a retrospective observational study conducted from September 2023 to December 2024 in the emergency department of Ibn Jazzar Hospital, including all patients diagnosed with CAP during the study period.• Inclusion criteria:All adult patients aged 18 years or older admitted for CAP . Exclusion criteria: Patients with incomplete records, those with nosocomial pneumonia, or those who refused to participate in the study.Thirty patients were included: 15 men (50%) and 15 women (50%), sex ratio = 1.  Mean age: 64.7 ± 17.6 years (range 17–98).  Patients over 60 years accounted for 73.3%.  COMORBIDITIES AND RISK FACTORS:Comorbidities were present in 60% of patients:  – Chronic respiratory disease (40%)  ,– Diabetes (30%)  ,– Hypertension (23.3%)   ;Smoking: 40%.CLINICAL FEATURES:Most frequent symptoms:  – Cough: 80%  ,– Dyspnea: 70%  ,– Fever: 56.7% .Vital signs:  – Temperature:  (fever in 40%)  ;– Heart rate: 87 bpm (tachycardia in 23.3%)  ;– Respiratory rate: 27.5 cycles/min  ;– SpO₂: 84.8% (<94% in 76.6%)  ;– Respiratory distress: 56.7% .PARACLINICAL DATA:– Chest X‑ray:   • Pulmonary consolidation: 30%  ; • Interstitial syndrome: 26.7%  . MANAGEMENT:Oxygen therapy required in 73.3% of cases;.Antibiotic therapy:  – Monotherapy (amoxicillin-clavulanic acid): 50% ; – Dual therapy (cefotaxime + levofloxacin): 50%.CLINICAL EVOLUTION (CRB‑65):Group 1 (score 0–1): 10 pts → no deaths  ;Group 2 (score 2): 15 pts →  4 stable, 2 worsened, 1 death  ;Group 3 (score ≥3):  3 stable, 1 death.Our study highlights epidemiological and clinical characteristics consistent with international data. The CRB‑65 score proved effective in stratifying severity and guiding hospitalization decisions.CAP remains a common and potentially severe condition. Early evaluation, severity assessment using tools like CRB‑65. Strengthening diagnostic and therapeutic resources is necessary for optimized emergency care.